OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IGSF8 is an innate immune checkpoint and cancer immunotherapy target
Yulong Li, Xiangyang Wu, Caibin Sheng, et al.
Cell (2024) Vol. 187, Iss. 11, pp. 2703-2716.e23
Closed Access | Times Cited: 17

Showing 17 citing articles:

Cell–cell communication: new insights and clinical implications
Jimeng Su, Ying Song, Zhipeng Zhu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 46

Cold and hot tumors: from molecular mechanisms to targeted therapy
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 46

The complex interplay of tumor-infiltrating cells in driving therapeutic resistance pathways
Dengxiong Li, Fanglin Shao, Qingxin Yu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 11

From mechanism to therapy: the journey of CD24 in cancer
Kai Zhao, Caifeng Wu, Xiangjun Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6

Circ_0001947 encapsulated by small extracellular vesicles promotes gastric cancer progression and anti-PD-1 resistance by modulating CD8+ T cell exhaustion
Bingyu Wang, Wenbo Liu, Mingming Zhang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6

SMARCD1 is a dual regulator of PD-L1 expression and cell proliferation facilitating tumor evasion
Gang Fu, Yutong Liu, Qian Chen, et al.
Pathology - Research and Practice (2025) Vol. 270, pp. 155975-155975
Closed Access

Behandlung des metastasierten Melanoms – Update 2025
Georg Lodde, Lea Jessica Albrecht, Dirk Schadendorf
DMW - Deutsche Medizinische Wochenschrift (2025) Vol. 150, Iss. 10, pp. 562-569
Closed Access

RAC2 inhibition enhances tumor sensitivity to NK cell-mediated cytotoxicity
Hui Guo, Jie Hu, Z. H. Wang, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 5, pp. e010931-e010931
Open Access

Targeting immune checkpoints in hepatocellular carcinoma therapy: toward combination strategies with curative potential
Jing Tong, Yongci Tan, Wenhao Ouyang, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access

Unraveling the NLRP Family: Structure, Function, Activation, Critical Influence on Tumor Progression, and Potential as Targets for Cancer Therapy
Xueqing Zhou, Yongguang Tao, Yongyong Shi
Cancer Letters (2024), pp. 217283-217283
Closed Access | Times Cited: 1

RNA Isoforms as Broad Targets for Cancer Immunotherapy
Guangyuan Li, Nathan Salomonis
DNA and Cell Biology (2024) Vol. 43, Iss. 8, pp. 363-368
Closed Access

An Improved Two-Shot Tracking Algorithm for Dynamics Analysis of Natural Killer Cells in Tumor Contexts
Yanqing Zhou, Y. W. Tang, Zhibing Li
Bioengineering (2024) Vol. 11, Iss. 6, pp. 540-540
Open Access

Multidimensional analysis of matched primary and recurrent glioblastoma identifies contributors to tumor recurrence influencing time to relapse
Tala Shekarian, Marie‐Françoise Ritz, Sabrina A. Hogan, et al.
Journal of Neuropathology & Experimental Neurology (2024)
Open Access

Page 1

Scroll to top